80 related articles for article (PubMed ID: 30173658)
1. Dosimetry and Toxicity Studies of the Novel Sulfonamide Derivative of Sulforhodamine 101([18F]SRF101) at a Preclinical Level.
Kreimerman I; Mora-Ramirez E; Reyes L; Bardiès M; Savio E; Engler H
Curr Radiopharm; 2019; 12(1):40-48. PubMed ID: 30173658
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of [18F]2B-SRF101: A Sulfonamide Derivative of the Fluorescent Dye Sulforhodamine 101.
Kreimerman I; Porcal W; Olivera S; Oliver P; Savio E; Engler H
Curr Radiopharm; 2017 Nov; 10(3):212-220. PubMed ID: 28956517
[TBL] [Abstract][Full Text] [Related]
3. Biological Assessment of a
Kreimerman I; Reyes AL; Paolino A; Pardo T; Porcal W; Ibarra M; Oliver P; Savio E; Engler H
Front Neurosci; 2019; 13():734. PubMed ID: 31379487
[TBL] [Abstract][Full Text] [Related]
4. Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates.
Quinn B; Dauer Z; Pandit-Taskar N; Schoder H; Dauer LT
BMC Med Imaging; 2016 Jun; 16(1):41. PubMed ID: 27317478
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of [
Salabert AS; Mora-Ramirez E; Beaurain M; Alonso M; Fontan C; Tahar HB; Boizeau ML; Tafani M; Bardiès M; Payoux P
Nucl Med Biol; 2018 Apr; 59():1-8. PubMed ID: 29413751
[TBL] [Abstract][Full Text] [Related]
6. (S)-4-(3-18F-fluoropropyl)-L-glutamic acid: an 18F-labeled tumor-specific probe for PET/CT imaging--dosimetry.
Smolarz K; Krause BJ; Graner FP; Wagner FM; Hultsch C; Bacher-Stier C; Sparks RB; Ramsay S; Fels LM; Dinkelborg LM; Schwaiger M
J Nucl Med; 2013 Jun; 54(6):861-6. PubMed ID: 23568366
[TBL] [Abstract][Full Text] [Related]
7. Preclinical pharmacokinetics, biodistribution, radiation dosimetry and acute toxicity studies required for regulatory approval of a Clinical Trial Application for a Phase I/II clinical trial of (111)In-BzDTPA-pertuzumab.
Lam K; Chan C; Done SJ; Levine MN; Reilly RM
Nucl Med Biol; 2015 Feb; 42(2):78-84. PubMed ID: 25459109
[TBL] [Abstract][Full Text] [Related]
8. Internal dose assessment of (-)-18F-flubatine, comparing animal model datasets of mice and piglets with first-in-human results.
Sattler B; Kranz M; Starke A; Wilke S; Donat CK; Deuther-Conrad W; Patt M; Schildan A; Patt J; Smits R; Hoepping A; Schoenknecht P; Steinbach J; Brust P; Sabri O
J Nucl Med; 2014 Nov; 55(11):1885-92. PubMed ID: 25286922
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution and Radiation Dosimetry for the Tau Tracer
Hsiao IT; Lin KJ; Huang KL; Huang CC; Chen HS; Wey SP; Yen TC; Okamura N; Hsu JL
J Nucl Med; 2017 Sep; 58(9):1498-1503. PubMed ID: 28336780
[No Abstract] [Full Text] [Related]
10. Human Radiation Dosimetry for the N-Methyl-D-Aspartate Receptor Radioligand 11C-CNS5161.
Dhawan V; Robeson W; Bjelke D; Chaly T; Graf K; Hellman M; Zhuo L; Mackay M; Eidelberg D
J Nucl Med; 2015 Jun; 56(6):869-72. PubMed ID: 25931480
[TBL] [Abstract][Full Text] [Related]
11. Radiation dose of 18F-FDG to lactating breasts, its effect on the effective dose and a more accurate effective dose from 18F-FDG.
Pencharz D; McMeekin H; Wagner T; Wickham F
Nucl Med Commun; 2016 Aug; 37(8):860-4. PubMed ID: 27115065
[TBL] [Abstract][Full Text] [Related]
12. Preclinical acute toxicity studies and rodent-based dosimetry estimates of the novel sigma-1 receptor radiotracer [(18)F]FPS.
Waterhouse RN; Stabin MG; Page JG
Nucl Med Biol; 2003 Jul; 30(5):555-63. PubMed ID: 12831995
[TBL] [Abstract][Full Text] [Related]
13. Novel weight-based dose threshold for 18F-NaF PET-CT imaging using advanced PET-CT systems: a potential tool for reducing radiation burden.
Marafi F; Esmail A; Rasheed R; Alkandari F; Usmani S
Nucl Med Commun; 2017 Sep; 38(9):764-770. PubMed ID: 28723715
[TBL] [Abstract][Full Text] [Related]
14.
Sadre Momtaz A; Safarnejad F
Phys Med; 2023 Mar; 107():102552. PubMed ID: 36857858
[TBL] [Abstract][Full Text] [Related]
15. 18F-Fluorothymidine radiation dosimetry in human PET imaging studies.
Vesselle H; Grierson J; Peterson LM; Muzi M; Mankoff DA; Krohn KA
J Nucl Med; 2003 Sep; 44(9):1482-8. PubMed ID: 12960196
[TBL] [Abstract][Full Text] [Related]
16. New Fetal Dose Estimates from 18F-FDG Administered During Pregnancy: Standardization of Dose Calculations and Estimations with Voxel-Based Anthropomorphic Phantoms.
Zanotti-Fregonara P; Chastan M; Edet-Sanson A; Ekmekcioglu O; Erdogan EB; Hapdey S; Hindie E; Stabin MG
J Nucl Med; 2016 Nov; 57(11):1760-1763. PubMed ID: 27261522
[TBL] [Abstract][Full Text] [Related]
17. Whole-body biodistribution and dosimetry estimates of a novel radiotracer for imaging of serotonin 4 receptors in brain: [¹⁸F]MNI-698.
Tavares AA; Caillé F; Barret O; Papin C; Lee H; Morley TJ; Fowles K; Holden D; Seibyl JP; Alagille D; Tamagnan GD
Nucl Med Biol; 2014; 41(5):432-9. PubMed ID: 24674817
[TBL] [Abstract][Full Text] [Related]
18. Dosimetry of 64Cu-DOTA-AE105, a PET tracer for uPAR imaging.
Persson M; El Ali HH; Binderup T; Pfeifer A; Madsen J; Rasmussen P; Kjaer A
Nucl Med Biol; 2014 Mar; 41(3):290-5. PubMed ID: 24533988
[TBL] [Abstract][Full Text] [Related]
19. Whole-body radiation dosimetry of 11C-carbonyl-URB694: a PET tracer for fatty acid amide hydrolase.
Boileau I; Bloomfield PM; Rusjan P; Mizrahi R; Mufti A; Vitcu I; Kish SJ; Houle S; Wilson AA; Tong J
J Nucl Med; 2014 Dec; 55(12):1993-7. PubMed ID: 25413137
[TBL] [Abstract][Full Text] [Related]
20. Preclinical radiation dosimetry for the novel SV2A radiotracer [18F]UCB-H.
Bretin F; Warnock G; Bahri MA; Aerts J; Mestdagh N; Buchanan T; Valade A; Mievis F; Giacomelli F; Lemaire C; Luxen A; Salmon E; Seret A; Plenevaux A
EJNMMI Res; 2013 May; 3(1):35. PubMed ID: 23647774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
